Abstract

ABSTRACT

Background

Renal patients with diabetes mellitus are at very high risk of death before and after chronic dialysis initiation. Risk factors for death in this population are not clearly identified.

Methods

We performed a retrospective survival analysis in 861 patients with diabetes mellitus consecutively followed up in the 2000–13 period in a nephrology setting.

Results

The mean age was 70 ± 10 years [men 65.2%; diabetes duration 13.7 ± 10.3 years; mean estimated glomerular filtration rate (eGFR) 42.4 ± 21.0 mL/min/1.73 m2). During follow-up (median 60 months; up 15 years), 263 patients died (184 before and 79 after dialysis initiation) and 183 started chronic dialysis. In multivariate analyses, age, elevated systolic and low diastolic arterial pressures, peripheral artery disease, cancer, loop diuretic use and atrial fibrillation at baseline and acute kidney injury (AKI), heart failure (HF) and amputation during follow-up were identified as risk factors for death. After adjustments on these parameters, eGFRs at the time of the first outpatient visit—eGFR <45 mL/min/1.73 m2 {hazard ratio [HR] 1.58 [95% confidence interval (CI) 1.15–2.17]}, P = 0.005 and eGFR <30 [HR 1.53 (1.05–2.05)], P = 0.004, but not eGFR <60—were powerful risk factors for death. When initiation of dialysis was entered into the multivariate models, it was not associated with a risk of premature death [HR 1.19 (95% CI 0.91–1.55), P = 0.2069], even in patients >80 years of age [HR 1.08 (95% CI 0.64–1.81), P = 0.7793].

Conclusions

In patients with diabetes mellitus, high systolic and low diastolic arterial pressure, peripheral artery disease and development of AKI and HF are significant risk factors for death. In addition to these parameters, eGFR <45 mL/min/1.73 m2 at the time of referral is also a powerful risk factor for death.

Details

Title
Renal function at the time of nephrology referral but not dialysis initiation as a risk for death in patients with diabetes mellitus
Author
Pinier, Cédric 1 ; Gatault, Philippe 2 ; Maud François 1 ; Barbet, Christelle 1 ; Longuet, Hélène 1 ; Rabot, Nolwenn 1 ; Noble, Johann 1 ; Bailly, Elodie 1 ; Buchler, Matthias 2 ; Sautenet, Bénédicte 3 ; Halimi, Jean-Michel 4 

 Service de Néphrologie-Immunologie clinique, Hôpital Bretonneau, CHU Tours, Tours, France 
 Service de Néphrologie-Immunologie clinique, Hôpital Bretonneau, CHU Tours, Tours, France; EA4245, François-Rabelais University, Tours, France 
 Service de Néphrologie-Immunologie clinique, Hôpital Bretonneau, CHU Tours, Tours, France; FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France; INSERM U1246, François-Rabelais University, Tours, France 
 Service de Néphrologie-Immunologie clinique, Hôpital Bretonneau, CHU Tours, Tours, France; EA4245, François-Rabelais University, Tours, France; FCRIN INI-CRCT Cardiovascular and Renal Clinical Trialists, France 
Pages
762-768
Publication year
2018
Publication date
Dec 2018
Publisher
Oxford University Press
ISSN
20488505
e-ISSN
20488513
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3169588974
Copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.